Skip to main content

Security report for ultomirishcp.com

Alexion Pharmaceuticals, Inc. · Healthcare · N/a

Medium risk. 4 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

70/100

Risk levelMedium

0–100, higher is better. How it is calculated

The website ultomirishcp.com serves as the official healthcare professional (HCP) resource for ULTOMIRIS®, a pharmaceutical product by Alexion Pharmaceuticals, Inc. It provides comprehensive information on the drug's indications, prescribing information, safety warnings including boxed warnings, dosing, administration, and patient support programs. The site targets healthcare professionals with detailed scientific and regulatory content, positioning ULTOMIRIS as a leading long-acting terminal complement inhibitor approved for multiple indications. The business model focuses on education, support, and access facilitation for healthcare providers and patients. Technically, the website employs a modern technology stack including Google Tag Manager, Google Analytics, Microsoft Clarity, Facebook Pixel, and Bing Ads for analytics and marketing. Hosting is via Amazon AWS infrastructure. The site demonstrates good mobile optimization, accessibility, and SEO practices, with a professional and consistent design. However, explicit privacy and cookie policies are not clearly found, and security headers are not evident in the provided data. From a security perspective, the site uses HTTPS and enforces domain registration protections but lacks DNSSEC and visible security policies or vulnerability disclosure mechanisms. The presence of a REMS program and boxed warnings indicates regulatory compliance and risk management. No WAF or blocking mechanisms were detected, and no critical vulnerabilities were found in the analysis. Overall, the website is a high-quality, professional pharmaceutical resource with strong business credibility and technical implementation. Privacy compliance could be improved by adding explicit policies and cookie consent mechanisms. Security posture is solid but could benefit from enhanced headers and DNSSEC. The site is safe for general audiences and effectively supports its healthcare professional user base.

Scanned

NIS2 and GDPR posture

GDPR outside view
58/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching ultomirishcp.com

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
67
Security headers
50
Email security
70
DNS health
75
Network security
100
GDPR outside view
58
Average
70

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

ULTOMIRIS is positioned as a specialized pharmaceutical product targeting rare and complex diseases such as NMOSD, gMG, aHUS, and PNH. The company leverages a direct-to-healthcare professional digital presence to disseminate critical prescribing and safety information, supported by patient assistance and access programs. The business model is focused on specialty pharmaceuticals with a strong emphasis on regulatory compliance and risk mitigation (REMS). The partnership ecosystem includes dedicated patient support and access navigator platforms, enhancing market penetration and patient adherence. The domain age and registration details align with the product launch timeline, indicating a legitimate and well-managed digital asset. Growth indicators include multi-indication approvals and comprehensive educational resources. Strategic observations suggest continued investment in digital engagement and compliance transparency could further strengthen market position.

Security posture

The website demonstrates a mature security posture with mandatory HTTPS usage and domain registration protections. The presence of a REMS program and boxed warnings reflects adherence to regulatory safety requirements. However, the absence of DNSSEC and security headers such as Content Security Policy, X-Frame-Options, and HSTS indicates room for improvement. No incident response or vulnerability disclosure information is publicly available, which could hinder rapid response to security issues. The extensive use of third-party analytics and marketing tools introduces potential privacy and security risks if not properly managed. Overall, the site is secure for its intended use but would benefit from enhanced security policies, headers, and transparency to align with best practices and compliance frameworks.

Recommendations

  1. Implement and publish a comprehensive privacy policy and cookie consent mechanism to improve privacy compliance.
  2. Enable DNSSEC on the domain to enhance DNS security and prevent spoofing.
  3. Add and configure security headers such as Content Security Policy, HSTS, X-Frame-Options, and X-Content-Type-Options.
  4. Publish a vulnerability disclosure policy or security.txt file to facilitate responsible reporting of security issues.
  5. Provide incident response contact information to improve transparency and readiness.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Alexion Pharmaceuticals, Inc.
Description
ULTOMIRIS is a treatment for adult patients with neuromyelitis optica spectrum disorder (NMOSD), generalized myasthenia gravis (gMG), atypical hemolytic uremic syndrome (aHUS), and paroxysmal nocturnal hemoglobinuria (PNH). The site provides healthcare professionals with prescribing information, safety information including boxed warnings, dosing and administration details, and patient support resources.
Key services
Product information dissemination, Prescribing and safety information, Patient support programs, Access and reimbursement resources
Content quality
excellent
Branding
consistent

Technology

Stack
Google Tag Manager, Google Analytics, Microsoft Clarity, Facebook Pixel, Bing Ads, Wistia video embeds, Evergage personalization, OneTrust (cookie consent placeholder)
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
75/100
Good practices seen
  • Use of HTTPS
  • Restricted access to prescribing information
  • REMS program for risk mitigation

Analytics and tracking

Services
Google Analytics, Microsoft Clarity, Facebook Pixel, Bing Ads, Evergage
Tracking level
extensive
Privacy practices
basic

Advertising

Ad networks
Bing Ads, Facebook Ads, DeepIntent, ContextWeb
Tracking pixels
Facebook Pixel, Microsoft Clarity, Evergage
Marketing tools
Evergage personalization, Microsoft Clarity
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is a professional healthcare provider resource for ULTOMIRIS pharmaceutical product.
  2. Content is comprehensive with detailed prescribing and safety information including boxed warnings.
  3. Multiple indications covered with gated modal navigation for detailed information.
  4. Strong branding and consistent design aligned with Alexion Pharmaceuticals.
  5. Extensive use of third-party analytics and marketing tools for user tracking and engagement.
  6. No privacy or cookie policy explicitly found on the main page content.
  7. Contact information for healthcare professional support is clearly provided with phone and email.
  8. No visible security.txt or vulnerability disclosure policy.
  9. Domain registration is recent but consistent with product launch timeline.
  10. No WAF or blocking mechanisms detected; content fully accessible.
Technical notes

Notes

The website is built on a modern technology stack with extensive use of analytics and marketing tools including Google Tag Manager, Google Analytics, Microsoft Clarity, Facebook Pixel, and Bing Ads. Hosting is on Amazon AWS, providing scalable and reliable infrastructure. The site is mobile optimized and accessible, with good SEO practices evident from meta tags and structured data. The use of JSON-LD structured data enhances search engine understanding and indexing. Performance is moderate, with multiple third-party scripts that may impact load times. No CMS was explicitly detected, suggesting a custom or proprietary platform. Technical risks include reliance on multiple third-party scripts and lack of DNSSEC. Opportunities exist to improve security headers and privacy compliance to reduce technical debt and enhance user trust.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with ultomirishcp.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review ultomirishcp.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.